Provided by Tiger Fintech (Singapore) Pte. Ltd.

GENSCRIPT BIO

17.450
-0.630-3.48%
Volume:14.41M
Turnover:252.45M
Market Cap:38.13B
PE:1.60
High:17.980
Open:17.980
Low:17.350
Close:18.080
52wk High:19.400
52wk Low:8.880
Shares:2.19B
HK Float Shares:2.19B
Volume Ratio:0.98
T/O Rate:0.66%
Dividend:- -
Dividend Rate:- -
EPS(LYR):10.873
ROE:-1.94%
ROA:2.56%
PB:1.11
PE(LYR):1.60
PS:5.91

Loading ...

BUZZ-U.S. STOCKS ON THE MOVE-Legend Biotech, Unity Software, MP Materials

Reuters
·
Jul 16

BUZZ-Legend Biotech up as Q2 sales for J&J-partnered blood cancer therapy rises

Reuters
·
Jul 16

Legend Biotech Reports $439 Million in Net Trade Sales for CARVYKTI® in Q2 2025

Reuters
·
Jul 16

EXCLUSIVE-US lawmakers renew concerns about GenScript's ties to China

Reuters
·
Jul 10

GenScript Biotech Corporation Awarded EcoVadis Silver Medal for Sustainability Efforts

Reuters
·
Jul 09

BRIEF-Genscript Biotech Says Unit Receives $213.8 Million Under R+A Agreement

Reuters
·
Jun 30

ProBio Nanjing Secures $213.8M from LaNova License Agreement

Reuters
·
Jun 30

ProBio Opens Flagship US Facility for Cell and Gene Therapy in New Jersey

Reuters
·
Jun 27

Legend Biotech Corporation Concludes Annual General Meeting

Reuters
·
Jun 13

Genscript Biotech Grants Over 7.4 Million Restricted Shares Under Award Scheme

MT Newswires Live
·
Jun 12

GenScript Biotech Announces New Restricted Share Grant Plan for Employees and Consultants

Reuters
·
Jun 11

Legend Biotech Corporation Names Peter Salovey as Lead Independent Director

Reuters
·
Jun 05

Genscript Biotech's Myeloma Drug Shows Progression-Free Survival in One-Third of Patients During Study

MT Newswires Live
·
Jun 04

Legend Biotech Announces Promising Phase 1 Results for LB2102 CAR-T Therapy in Lung Cancer Patients

Reuters
·
Jun 03

Legend Biotech to Reveal New CARVYKTI Data for Multiple Myeloma at 2025 ASCO and EHA Meetings

Reuters
·
May 23

Legend Biotech Corporation to Host Investor Event During American Society of Clinical Oncology Annual Meeting

Reuters
·
May 19

BUZZ-Legend Biotech slips after brokerages cut PT

Reuters
·
May 14

Legend Biotech USA Inc. Signs Lease for New Global Headquarters in Bridgewater, New Jersey

Reuters
·
May 14

Legend Biotech Corp reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 13

Legend Biotech Reports Q1 2025: Net Loss Widens to $100.9M, License Revenue Falls by $2.9M, CARVYKTI® Sales Reach $369M

Reuters
·
May 13